Lipopolysaccharide-induced Tumor Necrosis Factor-α Promoter Activity Is Inhibitor of Nuclear Factor-κB Kinase-dependent

This publication has 40 references indexed in Scilit:

• Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation
  Cell, 1998
• HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation
  Cell, 1998
• The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation
  Published by Elsevier ,1997
• Identification and Characterization of an IκB Kinase
  Cell, 1997
• MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
  Nature, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
  Science, 1994
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.
  The Journal of Experimental Medicine, 1990
• Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
  Science, 1985